Drug intelligence / Profile preview

VIAGENEX

Development stage
Unknown
Lead developer
Vivex Biologics
Modality
Cell Therapies
Administration
Surgical Implantation
01

Overview

VIAGENEX is a viable allogeneic bone matrix (VABM) developed by VIVEX Biologics, designed for use in orthopedic and spinal fusion procedures. Regulated as a Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) under Section 361 of the PHS Act, it is processed to preserve the native bone's regenerative components. The product provides a triad of bone-healing properties: an osteoconductive scaffold (mineralized and demineralized bone), osteoinductive potential (endogenous growth factors like Bone Morphogenetic Proteins), and osteogenic viable cells (including mesenchymal stem cells and osteoprogenitors). It is typically supplied as a cryopreserved graft that is thawed immediately before surgical implantation to ensure high cell viability and optimal clinical outcomes in promoting bone formation and fusion.

Brand names
VIAGENEX
Other names
Viable Allogeneic Bone MatrixTissue allograft

Beyond the preview

Go deeper on VIAGENEX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIAGENEX.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call